TY  - JOUR
AU  - Garcia-Romero, Ruth
AU  - Martinez-de-Zabarte-Fernandez, Jose Miguel 
AU  - Pujol-Muncunill, Gemma
AU  - Donat-Aliaga, Ester
AU  - Segarra-Canton, Oscar
AU  - Irastorza-Terradillos, Iñaki
AU  - Medina-Benitez, Enrique
AU  - Ruiz-Hernandez, Carlos Jose
AU  - Carrillo-Palau, Marta
AU  - Ros-Arnal, Ignacio
AU  - Rodriguez-Martinez, Alejandro
AU  - Escartin-Madurga, Laura
AU  - Gutierrez-Junquera, Carolina
AU  - Vicente-Santamaria, Saioa
AU  - Rodriguez-Belvis, Marta Velasco
AU  - Fernandez-Fernandez, Sonia
AU  - Alberto-Alonso, Jose Ramon
AU  - Montraveta, Montserrat
AU  - Torres-Peral, Ricardo
AU  - Navalon-Rubio, Maria
AU  - Navas-Lopez, Victor Manuel
AU  - de-Carpi, Javier Martin
PY  - 2021
DO  - 10.1007/s00431-021-04063-6
UR  - http://hdl.handle.net/10668/17825
T2  - European journal of pediatrics
AB  - Vedolizumab is a humanised monoclonal antibody that binds to integrin α4β7 expressed in T-cells, inhibiting its binding to the mucosal addressin cell adhesion molecule-1 (MAdCAM-1), which is specifically expressed in the small intestine and colon,...
LA  - en
PB  - Springer
KW  - Crohn’s disease
KW  - Ulcerative colitis
KW  - Children
KW  - Vedolizumab
KW  - T-Lymphocytes
KW  - Crohn Disease
KW  - Inflammatory Bowel Diseases
KW  - Intestine, Small
KW  - Cell Movement
KW  - Alopecia
KW  - Necrosis
TI  - Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study.
TY  - research article
VL  - 180
ER  -